[1]GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Neurol, 2024, 23(10): 973-1003.
[2]Wu S M, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[3]National Center for Cardiovascular Diseases the Writing Committee of the Report on cardiovascular health and diseases in China. Report on Cardiovascular Health and Diseases in China 2023: an updated summary[J]. Biomed Environ Sci, 2024, 37(9): 949-992.
[4]Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease[J]. Cochrane Database Syst Rev, 2019, 3(3): CD009825.
[5]Tucker W J, Fegers-Wustrow I, Halle M, et al. Exercise for primary and secondary prevention of cardiovascular disease[J]. J Am Coll Cardiol, 2022, 80(11): 1091-1106.
[6]Spagnoli L G, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke[J]. JAMA, 2004, 292(15): 1845-1852.
[7]Maida C D, Daidone M, Pacinella G, et al. Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases[J]. Int J Mol Sci, 2022, 23(4): 2397.
[8]Scott D A, Ponir C, Shapiro M D, et al. Associations between insulin resistance indices and subclinical atherosclerosis: a contemporary review[J]. Am J Prev Cardiol, 2024, 18: 100676.
[9]Simental-Mendía L E, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4): 299-304.
[10]Li F D, Wang Y, Shi B Q, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China[J]. Cardiovasc Diabetol, 2024, 23(1): 16.
[11]Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study[J]. Lancet Healthy Longev, 2023, 4(1): e23-e33.
[12]Li W P, Shen C N, Kong W Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study[J]. Cardiovasc Diabetol, 2024, 23(1): 292.
[13]Li H B, Qian F, Zuo Y T, et al. U-shaped relationship of high-density lipoprotein cholesterol and incidence of total, ischemic and hemorrhagic stroke: a prospective cohort study[J]. Stroke, 2022, 53(5): 1624-1632.
[14]Chen Z M, Iona A, Parish S, et al. Adiposity and risk of ischaemic and haemorrhagic stroke in 0.5 million Chinese men and women: a prospective cohort study[J]. Lancet Glob Health, 2018, 6(6): e630-e640.
[15]Persaud S R, Lieber A C, Donath E, et al. Obesity paradox in intracerebral hemorrhage[J]. Stroke, 2019, 50(4): 999-1002.
[16]Song S N, Zhang Y M, Qiao X L, et al. HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy[J]. Int J Gynaecol Obstet, 2022, 157(3): 694-701.
[17]Xu Z Y, Li C H, Wang N Z, et al. Association between the new TyG indicator-TyHGB and gestational diabetes mellitus: results from the case-control and prospective cohort studies[J]. J Transl Med, 2025, 23(1): 190.
[18]Zhao E F, Wang R M, Chen Y Q, et al. Evaluation of a new TyG indicator, TyHGB, in predicting non-alcoholic fatty liver disease: evidence from two Independent populations[J]. Lipids Health Dis, 2025, 24(1): 342.
[19]Zhao Y H, Hu Y S, Smith J P, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS)[J]. Int J Epidemiol, 2014, 43(1): 61-68.
[20]Sha T T, Yan Y, Cheng W W. Associations of childhood socioeconomic status with mid-life and late-life cognition in Chinese middle-aged and older population based on a 5-year period cohort study[J]. Int J Geriatr Psychiatry, 2018, 33(10): 1335-1345.
[21]Dai Y S, Junho C V C, Schieren L, et al. Cellular metabolism changes in atherosclerosis and the impact of comorbidities[J]. Front Cell Dev Biol, 2024, 12: 1446964.
[22]Lu H, Daugherty A.Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2015, 35(3): 485-491.
[23]Dziegielewska-Gesiak S. Metabolic syndrome in an aging society-role of oxidant-antioxidant imbalance and inflammation markers in disentangling atherosclerosis[J]. Clin Interv Aging, 2021, 16: 1057-1070.
[24]Hill M A, Yang Y, Zhang L P, et al. Insulin resistance, cardiovascular stiffening andcardiovascular disease[J]. Metabolism, 2021, 119: 154766.
[25]Huang R H, Lin Y F, Ye X M, et al. Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study[J]. Eur J Prev Cardiol, 2022, 29(11): 1531-1541.
[26]Del Brutto V J, Liebeskind D S, Romano J G, et al. Risk factors control and early recurrent cerebral infarction in patients with symptomatic intracranial atherosclerotic disease[J]. J Stroke Cerebrovasc Dis, 2021, 30(9): 105914.
[27]Ginsberg H N, Packard C J, Chapman M J, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society[J]. Eur Heart J, 2021, 42(47): 4791-4806.
[28]Schoch L, Alcover S, Padró T, et al. Update of HDL in atherosclerotic cardiovascular disease[J]. Clin Investig Arterioscler, 2023, 35(6): 297-314.
[29]Duong M, Uno K, Nankivell V, et al. Induction of obesity impairs reverse cholesterol transport in ob/ob mice[J]. PLoS One, 2018, 13(9): e0202102.
[30]Qie R R, Liu L L, Zhang D D, et al.Dose-response association between high-density lipoprotein cholesterol and stroke: a systematic review and meta-analysis of prospective cohort studies[J]. Prev Chronic Dis, 2021, 18: E45.
[31]Che B Z, Zhong C K, Zhang R J, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data[J]. Cardiovasc Diabetol, 2023, 22(1): 34.
[32]Chen Y X, Chang Z G, Liu Y J, et al. Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in the general population: a systematic review and meta-analysis of cohort studies[J]. Nutr Metab Cardiovasc Dis, 2022, 32(2): 318-329.
[33]Qu L J, Fang S, Lan Z, et al. Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS[J]. Cardiovasc Diabetol, 2024, 23(1): 215.
[34]Młynarska E, Bojdo K, Frankenstein H, et al. Endothelial dysfunction as the common pathway linking obesity, hypertension and atherosclerosis[J]. Int J Mol Sci, 2025, 26(20): 10096.
[35]Henning R J. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity[J]. Am J Cardiovasc Dis, 2021, 11(4): 504-529.
[36]Huo R R, Liao Q, Zhai L, et al. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study[J]. Cardiovasc Diabetol, 2024, 23(1): 30.
|